We are live on ! Find out more
CMRX

Chimerix, Inc.

Delisted

CMRX was delisted on the 17th of April, 2025.

85 hedge funds and large institutions have $168M invested in Chimerix, Inc. in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more capital invested

Capital invested by funds: $74.7M → $168M (+$93.1M)

65% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 20

10% less funds holding

Funds holding: 9485 (-9)

32% less call options, than puts

Call options by funds: $53K | Put options by funds: $78K

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

Holders
85
Holders Change
-9
Holders Change %
-9.57%
% of All Funds
1.85%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
33
Reduced
20
Closed
21
Calls
$53K
Puts
$78K
Net Calls
-$25K
Net Calls Change
-$29K
Name Holding Trade Value Shares
Change
Change in
Stake
ACH
1
ArrowMark Colorado Holdings
Colorado
$17.9M -$4.4M -1,429,096 -26%
RG
2
Redmile Group
California
$15.4M +$66.7K +21,670 +0.6%
BlackRock
3
BlackRock
New York
$14.6M +$522K +169,550 +5%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$11.7M +$277K +90,006 +3%
Morgan Stanley
5
Morgan Stanley
New York
$10.9M +$2.51M +816,955 +48%
Vanguard Group
6
Vanguard Group
Pennsylvania
$8.45M +$1.58M +514,727 +36%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$8.23M -$1.07K -347 -0%
Renaissance Technologies
8
Renaissance Technologies
New York
$7.6M +$1.34M +435,380 +33%
OM
9
Opaleye Management
Massachusetts
$6.35M +$1.57M +510,000 +53%
NLVP
10
New Leaf Venture Partners
New York
$5.83M
Citadel Advisors
11
Citadel Advisors
Florida
$4.95M +$3.22M +1,046,575 +1,049%
State Street
12
State Street
Massachusetts
$4.74M +$711K +231,103 +27%
Man Group
13
Man Group
United Kingdom
$3.55M -$2.15K -700 -0.1%
Millennium Management
14
Millennium Management
New York
$3.55M +$2.28M +739,573 +902%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$3.44M +$277K +89,894 +13%
PPA
16
Parametric Portfolio Associates
Washington
$2.78M +$369K +120,092 +23%
OAM
17
Oxford Asset Management
United Kingdom
$2.55M +$960K +311,869 +112%
N
18
Nuveen
North Carolina
$2.51M +$1.79M +581,291 New
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$2.41M +$229K +74,472 +15%
UBS Group
20
UBS Group
Switzerland
$2.36M +$1.68M +546,566 +420,435%
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$2.26M -$920K -298,905 -36%
Northern Trust
22
Northern Trust
Illinois
$2.19M +$2.37K +769 +0.2%
Connor, Clark & Lunn Investment Management (CC&L)
23
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.92M +$215K +69,867 +19%
6CM
24
683 Capital Management
New York
$1.43M +$92.5K +30,061 +10%
Goldman Sachs
25
Goldman Sachs
New York
$1.32M +$629K +204,582 +204%

CMRX Hedge Fund Activity: Q2 2019 in Review

85 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q2 2019, worth a combined $168M — up 125% from $74.7M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CMRX and 14 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 33 added.

The largest buyer was Citadel Advisors, adding an estimated $3.22M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $4.4M.

  • 85 institutional investors held Chimerix, Inc. (CMRX) as of Q2 2019, down from 94 in Q1 2019.
  • Funds reported $168M of Chimerix, Inc. stock for Q2 2019, up 125% quarter-over-quarter.
  • 14 funds opened new Chimerix, Inc. positions in Q2 2019 and 21 closed out, a net change of -7 holders.
  • The largest Chimerix, Inc. buyer in Q2 2019 was Citadel Advisors, an estimated $3.22M added.
  • The largest Chimerix, Inc. seller in Q2 2019 was ArrowMark Colorado Holdings, an estimated $4.4M sold.

Based on aggregated 13F filings for Q2 2019.